7074 Mild-to-moderate gastrointestinal adverse effects (including nausea, appetite loss, diarrhoea and constipation) were similar to those observed with conventional incretin preparations (including semaglutide), but were more frequent with tirzepatide than with semaglutide
And for those using GLP-1 weight loss medications, combining these insights with structured nutritional, movement, and behavioural support will help drive better outcomes and more sustainable results. Enhanced Community-First Support What sets Weight Watchers apart is the power of real human connection
The risk of DKA does not appear to be elevated with GLP-1 drugs in T1D a meaningful distinction from SGLT2 inhibitors
This gives patients peace of mind knowing they are receiving a professionally prepared version of one of the most studied and widely trusted GLP-1 medications available today
Notably, amycretin is being developed in both an oral and an injectable form
Morning injection peaks during peak eating windows (lunch/dinner), while evening injection may reduce breakfast hunger
